HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zaldumbide, A. Articles by Boulukos, K. E. Search for Related Content PubMed PubMed Citation Articles by Zaldumbide, A. Articles by Boulukos, K. E.

The Role of the Ets2 Transcription Factor in the Proliferation, Maturation, and Survival of Mouse Thymocytes¹

Institute of Signaling, Developmental Biology and Cancer Research, Center de Biochimie, Université de Nice, Parc Valrose, Nice, France

In this study, we investigated the effects of Ets2 expression on the proliferation, maturation, and survival of thymocytes by establishing transgenic mice that specifically express Ets2 or a dominant negative form of Ets2, ets2, in the thymus. We show that, in young animals, there are fewer T cells in ets2 transgenic thymi and that the maturation of these T cells is affected at the CD4^-CD8^- double-negative to CD4⁺CD8⁺ double-positive transition compared with wild-type littermate mice. Partial recovery in the number of thymocytes and full T cell maturation are restored with increasing age of ets2 transgenic animals. However, thymocytes from adult ets2 transgenic mice cultured ex vivo are more sensitive to cell death and to glucocorticoid-induced apoptosis than are T cells from control littermate mice. We also show that T cells from adult ets2 transgenic mice proliferate faster than their wild-type littermates. The proliferation and survival of these T cells are clearly affected upon apoptotic signals: glucocorticoid-induced apoptosis induces T cells from ets2 transgenic mice to continue to proliferate in vivo and to survive better ex vivo than T cells from control littermates. It has been shown that c-Myc expression is required for thymic proliferation and improves thymocyte survival of dexamethasone-treated animals. We show that the expression of c-Myc, an Ets2 target, is elevated in T cells freshly isolated from thymi of ets2 transgenic mice pretreated with dexamethasone. Together, these results show that Ets2 plays a role in the proliferation and survival of thymocytes, implicating a Myc-dependent pathway.

This article has been cited by other articles:

				Z. Shi, Z. Cai, S. Wen, C. Chen, C. Gendron, A. Sanchez, K. Patterson, S. Fu, J. Yang, D. Wildman, et al. Transcriptional Regulation of the Novel Toll-like Receptor Tlr13 J. Biol. Chem., July 31, 2009; 284(31): 20540 - 20547. [Abstract] [Full Text] [PDF]

				H. Kawagoe and G. C. Grosveld MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice Blood, December 15, 2005; 106(13): 4278 - 4286. [Abstract] [Full Text] [PDF]

				F. Takeshita, K. Suzuki, S. Sasaki, N. Ishii, D. M. Klinman, and K. J. Ishii Transcriptional Regulation of the Human TLR9 Gene J. Immunol., August 15, 2004; 173(4): 2552 - 2561. [Abstract] [Full Text] [PDF]

				I. Schmitz, L. K. Clayton, and E. L. Reinherz Gene expression analysis of thymocyte selection in vivo Int. Immunol., October 1, 2003; 15(10): 1237 - 1248. [Abstract] [Full Text] [PDF]

				N. Leider and D. Melamed Differential c-Myc Responsiveness to B Cell Receptor Ligation in B Cell-Negative Selection J. Immunol., September 1, 2003; 171(5): 2446 - 2452. [Abstract] [Full Text] [PDF]